咨询与建议

限定检索结果

文献类型

  • 45 篇 期刊文献

馆藏范围

  • 45 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 39 篇 医学
    • 24 篇 临床医学
    • 16 篇 基础医学(可授医学...
    • 9 篇 药学(可授医学、理...
    • 4 篇 中西医结合
    • 2 篇 公共卫生与预防医...
  • 17 篇 理学
    • 14 篇 生物学
    • 8 篇 统计学(可授理学、...
    • 1 篇 数学
    • 1 篇 化学
  • 5 篇 工学
    • 3 篇 计算机科学与技术...
    • 3 篇 生物工程
    • 1 篇 控制科学与工程
  • 2 篇 农学

主题

  • 7 篇 type 2 diabetes
  • 4 篇 alirocumab
  • 4 篇 open-label exten...
  • 4 篇 pcsk9
  • 3 篇 glycaemic contro...
  • 3 篇 ldl-c
  • 3 篇 prediabetes
  • 2 篇 biomarkers
  • 2 篇 personalised med...
  • 2 篇 pharmacodynamics
  • 2 篇 spatio-temporal ...
  • 2 篇 genome
  • 2 篇 navigation behav...
  • 2 篇 physical activit...
  • 2 篇 familial hyperch...
  • 2 篇 disease progress...
  • 2 篇 ectopic fat
  • 2 篇 pharmacokinetics
  • 2 篇 highly correlate...
  • 2 篇 aging

机构

  • 6 篇 sanofi aventis d...
  • 6 篇 univ oxford well...
  • 6 篇 eli lilly reg op...
  • 6 篇 cnr inst neurosc...
  • 5 篇 univ southern de...
  • 5 篇 regeneron pharma...
  • 5 篇 sanofi biostat &...
  • 5 篇 univ eastern fin...
  • 5 篇 newcastle univ i...
  • 4 篇 tech univ munich...
  • 4 篇 univ oxford radc...
  • 4 篇 duke univ med ct...
  • 4 篇 swiss inst bioin...
  • 4 篇 kuopio univ hosp...
  • 4 篇 churchill hosp n...
  • 4 篇 tech univ denmar...
  • 4 篇 chu dijon bourgo...
  • 3 篇 oslo univ hosp l...
  • 3 篇 univ montreal mo...
  • 3 篇 inst rech clin m...

作者

  • 7 篇 brunak soren
  • 7 篇 ruetten hartmut
  • 7 篇 pedersen oluf
  • 7 篇 walker mark
  • 7 篇 franks paul w.
  • 7 篇 mari andrea
  • 6 篇 giordano giusepp...
  • 6 篇 adamski jerzy
  • 6 篇 schwenk jochen m...
  • 6 篇 rutters femke
  • 6 篇 pearson ewan
  • 6 篇 frost gary
  • 6 篇 vinuela ana
  • 6 篇 hansen tue h.
  • 6 篇 pavo imre
  • 6 篇 kokkola tarja
  • 6 篇 mahajan anubha
  • 6 篇 hansen torben
  • 5 篇 mcdonald timothy...
  • 5 篇 hattersley andre...

语言

  • 43 篇 英文
  • 1 篇 其他
检索条件"机构=Sanofi Aventis R&D Biostat & Programming"
45 条 记 录,以下是31-40 订阅
The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI dIrECT study (vol 63, pg 744, 2020)
收藏 引用
dIABETOLOGIA 2021年 第1期64卷 260-261页
作者: Koivula, robert W. Atabaki-Pasdar, Naeimeh Giordano, Giuseppe N. White, Tom Adamski, Jerzy Bell, Jimmy d. Beulens, Joline Brage, Soren Brunak, Soren de Masi, Federico dermitzakis, Emmanouil T. Forgie, Ian M. Frost, Gary Hansen, Torben Hansen, Tue H. Hattersley, Andrew Kokkola, Tarja Kurbasic, Azra Laakso, Markku Mari, Andrea Mcdonald, Timothy J. Pedersen, Oluf rutters, Femke Schwenk, Jochen M. Teare, Harriet J. A. Thomas, E. Louise Vinuela, Ana Mahajan, Anubha McCarthy, Mark I. ruetten, Hartmut Walker, Mark Pearson, Ewan Pavo, Imre Franks, Paul W. Lund Univ Skane Univ Hosp Malmo Dept Clin Sci Genet & Mol Epidemiol CRC Bldg 91Level 12Jan Waldenstroms Gata 35 SE-20502 Malmo Sweden Univ Oxford Radcliffe Dept Med Oxford Ctr Diabet Endocrinol & Metab Oxford England Univ Cambridge Sch Clin Med MRC Epidemiol Unit Cambridge England German Res Ctr Environm Hlth Helmholtz Zentrum Munchen Genome Anal Ctr Res Unit Mol Endocrinol & Metab Neuherberg Germany Tech Univ Munich Lehrstuhl Expt Genet Freising Weihenstephan Germany Natl Univ Singapore Yong Loo Lin Sch Med Dept Biochem Singapore Singapore Univ Westminister Dept Life Sci Res Ctr Optimal Hlth London England Univ Amsterdam Locat VU Univ Amsterdam Publ Hlth Res Inst Dept Epidemiol & BiostatMed Ctr Amsterdam Netherlands Univ Southern Denmark Fac Hlth Sci Odense Denmark Univ Copenhagen Novo Nordisk Fdn Ctr Prot Res Copenhagen Denmark Tech Univ Denmark Dept Bio & Hlth Informat Lyngby Denmark Univ Geneva Med Sch Dept Genet Med & Dev Geneva Switzerland Univ Geneva Inst Genet & Genom Geneva iGE3 Geneva Switzerland Swiss Inst Bioinformat Geneva Switzerland Univ Dundee Ninewells Hosp Sch Med Populat Hlth & Genom Dundee Scotland Imperial Coll London Div Diabet Endocrinol & Metab Dept Med Nutr & Dietet Res Grp Hammersmith Campus London England Univ Copenhagen Fac Hlth & Med Sci Novo Nordisk Fdn Ctr Basic Metab Res Copenhagen Denmark Univ Exeter Med Sch NIHR Exeter Clin Res Facil Exeter Devon England Univ Exeter Med Sch Inst Biomed & Clin Sci Exeter Devon England Univ Eastern Finland Dept ofMedicine Kuopio Finland Kuopio Univ Hosp Kuopio Finland CNR Inst Neurosci Padua Italy KTH Royal Inst Technol Affin Prote Sci Life Lab Stockholm Sweden Univ Oxford Nuffield Dept Populat Hlth HeLEX Old Rd Campus Oxford England Univ Oxford Wellcome Ctr Human Genet Oxford England Churchill Hosp NIHR Oxford Biomed Res Ctr Oxford England Genentech Inc Human Genet South San Francisco CA USA Sanofi Aventis Deutschland GmbH R&D Frankfurt G
Unfortunately, 'Present address' was omitted from one of the addresses provided for Mark I. McCarthy (#26).
来源: 评论
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI dIrECT study
收藏 引用
CELL rEPOrTS MEdICINE 2022年 第1期3卷 100477-100477页
作者: Wesolowska-Andersen, Agata Brorsson, Caroline A. Bizzotto, roberto Mari, Andrea Tura, Andrea Koivula, robert Mahajan, Anubha Vinuela, Ana Tajes, Juan Fernandez Sharma, Sapna Haid, Mark Prehn, Cornelia Artati, Anna Hong, Mun-Gwan Musholt, Petra B. Kurbasic, Azra de Masi, Federico Tsirigos, Kostas Pedersen, Helle Krogh Gudmundsdottir, Valborg Thomas, Cecilia Engel Banasik, Karina Jennison, Chrisopher Jones, Angus Kennedy, Gwen Bell, Jimmy Thomas, Louise Frost, Gary Thomsen, Henrik Allin, Kristine Hansen, Tue Haldor Vestergaard, Henrik Hansen, Torben rutters, Femke Elders, Petra T'Hart, Leen Bonnefond, Amelie Canouil, Mickael Brage, Soren Kokkola, Tarja Heggie, Alison McEvoy, donna Hattersley, Andrew Mcdonald, Timothy Teare, Harriet ridderstrale, Martin Walker, Mark Forgie, Ian Giordano, Giuseppe N. Froguel, Philippe Pavo, Imre ruetten, Hartmut Pedersen, Oluf dermitzakis, Emmanouil Franks, Paul W. Schwenk, Jochen M. Adamski, Jerzy Pearson, Ewan McCarthy, Mark, I Brunak, Soren Univ Oxford Wellcome Ctr Human Genet Oxford England Tech Univ Denmark Dept Hlth Technol Lyngby Denmark Univ Copenhagen Novo Nordisk Fdn Fac Hlth & Med Sci Ctr Prot Res Copenhagen Denmark CNR Inst Neurosci Padua Italy Univ Geneva Dept Genet Med & Dev Med Sch Geneva Switzerland German Res Ctr Environm Hlth GmbH Res Unit Mol Endocrinol & Metab Helmholtz Zentrum Muenchen Neuherberg Germany KTH Royal Inst Technol Sch Engn Sci Chem Biotechnol & Hlth Sci Life Lab Affin Prote Solna Sweden Sanofi Aventis Deutschland GmbH Translat Med & Clin Pharmacol TMCP R&D Global Dev Frankfurt Germany Lund Univ Clin Sci Malmo Sweden Univ Bath Dept Math Sci Bath Avon England Univ Exeter Med Sch Exeter Devon England Univ Dundee Immunoassay Biomarker Core Lab Shool Med Dundee Scotland Univ Westminster Res Ctr Optimal Hlth Dept Life Sci London Scotland Imperial Coll London Fac Med Sect Nutr Res Hammersmith Campus London Scotland Univ Copenhagen Novo Nordisk Fdn Fac Hlth & Med Sci Ctr Basic Metab Res Copenhagen Denmark Amsterdam UMC Locat VUmc Dept Epidemiol & Biostat Amsterdam Publ Hlth Res Inst Amsterdam Netherlands Amsterdam UMC Locat VUmc Dept Gen Practice Amsterdam Publ Hlth Res Inst Amsterdam Netherlands Leiden Univ Med Ctr Dept Cell & Chem Biol Leiden Netherlands Univ Lille Lille Univ Hosp European Genom Inst Diabet EGID Inst Pasteur LilleINSERM UMR 1283CNRS UMR 8199 Lille France Univ Cambridge MRC Epidemiol Unit Sch Clin Med Cambridge England Univ Eastern Finland Dept Med Kuopio Finland Newcastle Univ Inst Cellular Med Newcastle England Royal Victoria Infirm Diabet Res Network Newcastle England Univ Oxford Fac Law Ctr Hlth Law & Emerging Technol HeLEX Oxford England Newcastle Univ Fac Med Sci Translat & Clin Res Inst Newcastle England Univ Dundee Dundee Scotland Eli Lilly Reg Operat GmbH Vienna Austria Tech Univ Munich Lehrstuhl Expt Genet Freising Weihenstephan Germany Natl Univ Singapore Yong Loo Lin Sch Med Dept Biochem 8 M
The presentation and underlying pathophysiology of type 2 diabetes (T2d) is complex and heterogeneous. recent studies attempted to stratify T2d into distinct subgroups using data-driven approaches, but their clinical ... 详细信息
来源: 评论
The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI dIrECT study
收藏 引用
dIABETOLOGIA 2020年 第4期63卷 744-756页
作者: Koivula, robert W. Atabaki-Pasdar, Naeimeh Giordano, Giuseppe N. White, Tom Adamski, Jerzy Bell, Jimmy d. Beulens, Joline Brage, Soren Brunak, Soren de Masi, Federico dermitzakis, Emmanouil T. Forgie, Ian M. Frost, Gary Hansen, Torben Hansen, Tue H. Hattersley, Andrew Kokkola, Tarja Kurbasic, Azra Laakso, Markku Mari, Andrea Mcdonald, Timothy J. Pedersen, Oluf rutters, Femke Schwenk, Jochen M. Teare, Harriet J. A. Thomas, E. Louise Vinuela, Ana Mahajan, Anubha McCarthy, Mark I. ruetten, Hartmut Walker, Mark Pearson, Ewan Pavo, Imre Franks, Paul W. Lund Univ Genet & Mol Epidemiol Skane Univ Hosp Malmo Dept Clin SciCRC Bldg 91Level 12Jan Waldenstroms Gata 35 SE-20502 Malmo Sweden Univ Oxford Radcliffe Dept Med Oxford Ctr Diabet Endocrinol & Metab Oxford England Univ Cambridge Sch Clin Med MRC Epidemiol Unit Cambridge England German Res Ctr Environm Hlth Helmholtz Zentrum Munchen Genome Anal Ctr Res Unit Mol Endocrinol & Metab Neuherberg Germany Tech Univ Munich Lehrstuhl Expt Genet Freising Weihenstephan Germany Natl Univ Singapore Yong Loo Lin Sch Med Dept Biochem Singapore Singapore Univ Westminister Dept Life Sci Res Ctr Optimal Hlth London England Amsterdam Univ Med Ctr Locat VU Univ Med Ctr Amsterdam Publ Hlth Res Inst Dept Epidemiol & Biostat Amsterdam Netherlands Univ Southern Denmark Fac Hlth Sci Odense Denmark Univ Copenhagen Novo Nordisk Fdn Ctr Prot Res Copenhagen Denmark Tech Univ Denmark Dept Bio & Hlth Informat Lyngby Denmark Univ Geneva Sch Med Dept Genet Med & Dev Geneva Switzerland Univ Geneva IGE3 Geneva Switzerland Swiss Inst Bioinformat Geneva Switzerland Univ Dundee Ninewells Hosp Populat Hlth & Genom Sch Med Dundee Scotland Imperial Coll London Nutr & Dietet Res Grp Dept Med Div Diabet Endocrinol & Metab Hammersmith Campus London England Univ Copenhagen Novo Nordisk Fdn Ctr Basic Metab Res Fac Hlth & Med Sci Copenhagen Denmark Univ Exeter Sch Med NIHR Exeter Clin Res Facil Exeter Devon England Univ Exeter Sch Med Inst Biomed & Clin Sci Exeter Devon England Univ Eastern Finland Dept Med Kuopio Finland Kuopio Univ Hosp Kuopio Finland CNR Inst Neurosci Padua Italy KTH Royal Inst Technol Affin Prote Sci Life Lab Stockholm Sweden Univ Oxford Nuffield Dept Populat Hlth HeLEX Old Rd Campus Oxford England Univ Oxford Wellcome Ctr Human Genet Oxford England Churchill Hosp NIHR Oxford Biomed Res Ctr Oxford England Genentech Inc Human Genet San Francisco CA USA Sanofi Aventis Deutschland GmbH R&D Frankfurt Germany Newcastle Univ Inst C
Aims/hypothesis It is well established that physical activity, abdominal ectopic fat and glycaemic regulation are related but the underlying structure of these relationships is unclear. The previously proposed twin-cy... 详细信息
来源: 评论
differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of AdPKd
收藏 引用
PHYSIOLOGICAL rEPOrTS 2016年 第12期4卷 12846-12846页
作者: rogers, Kelly A. Moreno, Sarah E. Smith, Laurie A. Husson, Herve Bukanov, Nikolay O. Ledbetter, Steven r. Budman, Yeva Lu, Yuefeng Wang, Bing Ibraghimov-Beskrovnaya, Oxana Natoli, Thomas A. Sanofi Genzyme R&D Ctr Dept Rare Renal Dis Res 49 New York Ave Framingham MA 02151 USA Sanofi Corp Dept Analyt Res & Dev Waltham MA USA Sanofi Genzyme R&D Ctr Dept Biostat & Programming Framingham MA USA
development of a disease-modifying therapy to treat autosomal dominant polycystic kidney disease (AdPKd) requires well-characterized preclinical models that accurately reflect the pathology and biochemical changes ass... 详细信息
来源: 评论
Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies)
收藏 引用
AMErICAN JOUrNAL OF CArdIOLOGY 2016年 第1期118卷 56-63页
作者: Teramoto, Tamio Kobayashi, Masahiko Uno, Kiyoko Takagi, Yoshiharu Matsuoka, Osamu Sugimoto, Masayuki Inoue, Satoshi Minami, Fumiko Baccara-dinet, Marie Therese Teikyo Acad Res Ctr Tokyo Japan Sanofi Therapeut Strategy Unit Asia Pacific R&D Tokyo Japan Sanofi Med Operat Primary & Consumer Hlth Care Med Tokyo Japan Sanofi Clin Sci & Operat Biostat & Programming R&DBiostat Tokyo Japan Heishinkai Med Grp Inc ToCROM Clin Tokyo Japan Koganeibashi Sakura Clin Tokyo Japan Heishinaki Med Grp Inc OCROM Clin Osaka Japan Daiwa Hosp Osaka Japan Sanofi Dev & Launch Unit PCSK9 Montpellier France
We assessed the safety and tolerability of ascending single doses of alirocumab in healthy Japanese subjects and evaluated the effect of alirocumab at 3 doses (50, 75, 150 mg) on low density lipoprotein cholesterol (L...
来源: 评论
discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI dIrECT Consortium
收藏 引用
dIABETOLOGIA 2019年 第9期62卷 1601-1615页
作者: Koivula, robert W. Forgie, Ian M. Kurbasic, Azra Vinuela, Ana Heggie, Alison Giordano, Giuseppe N. Hansen, Tue H. Hudson, Michelle Koopman, Anitra d. M. rutters, Femke Siloaho, Maritta Allin, Kristine H. Brage, Soren Brorsson, Caroline A. dawed, Adem Y. de Masi, Federico Groves, Christopher J. Kokkola, Tarja Mahajan, Anubha Perry, Mandy H. rauh, Simone P. ridderstrale, Martin Teare, Harriet J. A. Thomas, E. Louise Tura, Andrea Vestergaard, Henrik White, Tom Adamski, Jerzy Bell, Jimmy d. Beulens, Joline W. Brunak, Soren dermitzakis, Emmanouil T. Froguel, Philippe Frost, Gary Gupta, ramneek Hansen, Torben Hattersley, Andrew Jablonka, Bernd Kaye, Jane Laakso, Markku Mcdonald, Timothy J. Pedersen, Oluf Schwenk, Jochen M. Pavo, Imre Mari, Andrea McCarthy, Mark I. ruetten, Hartmut Walker, Mark Pearson, Ewan Franks, Paul W. Lund Univ Skane Univ Hosp Malmo Genet & Mol Epidemiol Unit Dept Clin SciDiabet CtrCRC Bldg 91Level 10Jan Waldenstroms Gata 35 SE-20502 Malmo Sweden Univ Oxford Radcliffe Dept Med Oxford Ctr Diabet Endocrinol & Metab Oxford England Univ Dundee Med Res Inst Populat Hlth & Genom Dundee DD1 9SY Scotland Univ Geneva Med Sch Dept Genet Med & Dev Geneva Switzerland Univ Geneva Inst Genet & Genom Geneva iGE3 Geneva Switzerland Swiss Inst Bioinformat Geneva Switzerland Newcastle Univ Inst Cellular Med Diabet Newcastle Upon Tyne Tyne & Wear England Univ Copenhagen Fac Hlth & Med Sci Novo Nordisk Fdn Ctr Basic Metab Res Copenhagen Denmark Univ Exeter Med Sch NIHR Exeter Clin Res Facil Exeter Devon England Vrije Univ Amsterdam Med Ctr Amsterdam Publ Hlth Res Inst Dept Epidemiol & Biostat Amsterdam Netherlands Univ Eastern Finland Dept Med Kuopio Finland Kuopio Univ Hosp Kuopio Finland Bispebjerg & Frederiksberg Hosp Dept Clin Epidemiol Copenhagen Denmark Univ Cambridge Sch Clin Med MRC Epidemiol Unit Cambridge England Univ Southern Denmark Fac Hlth Sci Odense Denmark Tech Univ Denmark Dept Bio & Hlth Informat Lyngby Denmark Univ Oxford Wellcome Ctr Human Genet Oxford England Lund Univ Skane Univ Hosp Malmo Clin Obes Dept Clin Sci Malmo Sweden Novo Nordisk AS Soborg Denmark Univ Oxford Nuffield Dept Populat Hlth HeLEX Old Rd Campus Oxford England Univ Westminster Dept Life Sci Res Ctr Optimal Hlth London England CNR Inst Neurosci Padua Italy German Res Ctr Environm Hlth GmbH Helmholtz Zentrum Muenchen Inst Epidemiol 2 Neuherberg Germany Univ Copenhagen Novo Nordisk Fdn Ctr Prot Res Copenhagen Denmark Imperial Coll London Sch Publ Hlth Dept Genom Common Dis London England Univ Lille CNRS Pasteur Inst Lille Lille France Imperial Coll London Div Diabet Endocrinol & Metab Dept Med Nutr & Dietet Res Grp Hammersmith Campus London England Univ Exeter Med Sch Inst Biomed & Clin Sci Exeter Devon England Sanofi Aventis Deuts
Aims/hypothesis Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) diabetes research on Patient Stratification (dIrECT) epidemiological cohorts at baseline and follow-up examinations (1... 详细信息
来源: 评论
Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-dIrECT study
收藏 引用
GENOME MEdICINE 2020年 第1期12卷 109-109页
作者: Gudmundsdottir, Valborg Pedersen, Helle Krogh Mazzoni, Gianluca Allin, Kristine H. Artati, Anna Beulens, Joline W. Banasik, Karina Brorsson, Caroline Cederberg, Henna Chabanova, Elizaveta de Masi, Federico Elders, Petra J. Forgie, Ian Giordano, Giuseppe N. Grallert, Harald Gupta, ramneek Haid, Mark Hansen, Torben Hansen, Tue H. Hattersley, Andrew T. Heggie, Alison Hong, Mun-Gwan Jones, Angus G. Koivula, robert Kokkola, Tarja Laakso, Markku Longreen, Peter Mahajan, Anubha Mari, Andrea Mcdonald, Timothy J. McEvoy, donna Musholt, Petra B. Pavo, Imre Prehn, Cornelia ruetten, Hartmut ridderstrale, Martin rutters, Femke Sharma, Sapna Slieker, roderick C. Syed, Ali Tajes, Juan Fernandez Thomas, Cecilia Engel Thomsen, Henrik S. Vangipurapu, Jagadish Vestergaard, Henrik Vinuela, Ana Wesolowska-Andersen, Agata Walker, Mark Adamski, Jerzy Schwenk, Jochen M. McCarthy, Mark, I Pearson, Ewan dermitzakis, Emmanouil Franks, Paul W. Pedersen, Oluf Brunak, Soren Tech Univ Denmark Dept Bio & Hlth Informat Lyngby Denmark Univ Copenhagen Novo Nordisk Fdn Ctr Basic Metab Res Fac Hlth & Med Sci Copenhagen Denmark Univ Copenhagen Novo Nordisk Fdn Ctr Prot Res Fac Hlth & Med Sci Copenhagen Denmark Bispebjerg & Frederiksberg Hosp Ctr Clin Res & Prevent Capital Reg Copenhagen Denmark German Res Ctr Environm Hlth Res Unit Mol Endocrinol & Metab Helmholtz Zentrum Muenchen Neuherberg Germany Amsterdam UMC Dept Epidemiol & Biostat VUmc Amsterdam Publ Hlth Res Inst Amsterdam Netherlands Univ Med Ctr Utrecht Julius Ctr Hlth Sci & Primary Care Utrecht Netherlands Helsinki Univ Hosp Abdominal Ctr Dept Endocrinol Helsinki Finland Copenhagen Univ Hosp Herlev Gentofte Dept Diagnost Radiol Herlev Denmark Amsterdam UMC Dept Gen Practice Locat VUmc Amsterdam Publ Hlth Res Inst Amsterdam Netherlands Univ Dundee Ninewells Hosp Sch Med Dundee Scotland Lund Univ Skane Univ Hosp Lund Univ Diabet Ctr Clin Res CtrGenet & Mol Epidemiol UnitDept Clin Malmo Sweden German Ctr Diabet Res DZD eV Neuherberg Germany Helmholtz Zentrum Munchen Res Unit Mol Epidemiol Inst Epidemiol Neuherberg Germany Helmholtz Zentrum Munchen Clin Cooperat Grp Type 2 Diabet Munich Germany Ludwig Maximilians Univ Munchen Munich Germany Helmholtz Zentrum Munchen Clin Cooperat Grp Nutrigen & Type 2 Diabet Munich Germany Tech Univ Munich Munich Germany Novo Nordisk Res Ctr Oxford Oxford England Univ Southern Denmark Fac Hlth Sci Odense Denmark Slagelse Hosp Dept Cardiol & Endocrinol Slagelse Denmark Univ Exeter Coll Med & Hlth Inst Clin & Biol Sci Exeter Devon England Newcastle Univ Inst Cellular Med Diabet Newcastle Upon Tyne Tyne & Wear England KTH Royal Inst Technol Sch Engn Sci Chem Biotechnol & Hlth Sci Life Lab Affin Prote Solna Sweden Univ Oxford Churchill Hosp Oxford Ctr Diabet Endocrinol & Metab Oxford England Univ Eastern Finland Inst Clin Med Internal Med Kuopio Finland Univ Oxford Wellcome Ctr Human Genet Oxford England CN
Background The rising prevalence of type 2 diabetes (T2d) poses a major global challenge. It remains unresolved to what extent transcriptomic signatures of metabolic dysregulation and T2d can be observed in easily acc... 详细信息
来源: 评论
Analytical and statistical comparability of generic enoxaparins from the US market with the originator product
收藏 引用
JOUrNAL OF PHArMACEUTICAL ANd BIOMEdICAL ANALYSIS 2015年 115卷 431-442页
作者: Mourier, Pierre A. J. Agut, Christophe Souaifi-Amara, Hajer Herman, Frederic Viskov, Christian Sanofi F-94403 Vitry Sur Seine France Sanofi R&D F-34184 Montpellier France Experis IT Life Sci F-92723 Nanterre France Sanofi CMC Biostat & Programming Ctr Rech Vitry Sur Seine F-94403 Vitry Sur Seine France
Low-molecular-weight heparins (LMWHs) are complex anticoagulant drugs, made from heparin porcine mucosa starting material. Enoxaparin sodium manufactured by sanofi is one of the most widely prescribed LMWHs and has be... 详细信息
来源: 评论
diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients
收藏 引用
JOUrNAL OF HEPATOLOGY 2015年 第5期63卷 1133-1138页
作者: Jepsen, Peter Watson, Hugh Andersen, Per Kragh Vilstrup, Hendrik Aarhus Univ Hosp Dept Gastroenterol & Hepatol DK-8000 Aarhus Denmark Aarhus Univ Hosp Dept Clin Epidemiol DK-8000 Aarhus Denmark Sanofi Aventis R&D Paris France Univ Copenhagen Inst Publ Hlth Dept Biostat Copenhagen Denmark
Background & Aims: It remains unclear whether diabetes increases the risk for hepatic encephalopathy (HE) in cirrhotic patients. We examined this question using data from three randomized trials of satavaptan, a v... 详细信息
来源: 评论
dose-finding studies, MCP-Mod, model selection, and model averaging: Two applications in the real world
收藏 引用
CLINICAL TrIALS 2014年 第4期11卷 476-484页
作者: Verrier, dominique Sivapregassam, Sindou Solente, Anne-Catherine Sanofi R&D Biostat & Programming Dept F-34184 Montpellier France Inserm DGOS CIE 802 Ctr Invest Clin Epidemiol Clin Antilles Guyane Guyane France Sanofi R&D Dept Biostat & Programming Paris France
Background Phase II clinical trials are important milestones to determine whether a dose-effect exists and to decide on future doses to use in confirmatory studies. To take into account the overall shape of the dose r...
来源: 评论